Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Monoclonal antibody classification based on epitope-binding using differential antigen disruption.

Ergang Shi1, Wen Fury, Wentian Li

  • 1Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA. ergang.shi@regeneron.com <ergang.shi@regeneron.com>

Journal of Immunological Methods
|July 13, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticoagulation with mechanistically distinct FXI/FXIa antibodies amrecibart (REGN9933A2) and cenvacibart (REGN7508Cat).

Blood·2026
Same author

Structures of complete extracellular assemblies of type I and type II Oncostatin M receptor complexes.

Nature communications·2024
Same author

Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone.

Nature·2024
Same author

A Tetravalent Bispecific Antibody Selectively Inhibits Diverse FGFR3 Oncogenic Variants.

Cancer research·2024
Same author

Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain.

Neurobiology of pain (Cambridge, Mass.)·2023
Same author

TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells.

Cell reports methods·2023

A new differential antigen disruption method rapidly classifies monoclonal antibodies (mAbs) by epitope binding. This technique offers a faster, more scalable alternative to traditional competition assays for antibody profiling.

Area of Science:

  • Immunology
  • Biotechnology
  • Bioinformatics

Background:

  • Classifying monoclonal antibodies (mAbs) by epitope binding is crucial for understanding antibody function.
  • Current methods like competition assays are time-consuming, labor-intensive, and limited in scale.

Purpose of the Study:

  • To develop a rapid and scalable method for classifying antigen-reactive mAbs based on their epitope-binding properties.
  • To overcome the limitations of traditional competition assays in antibody profiling.

Main Methods:

  • A novel differential antigen disruption procedure was developed.
  • This method measures antibody binding signals to structurally disrupted antigens.
  • Antibodies are clustered based on the similarity of their binding profiles.

Related Experiment Videos

Main Results:

  • The differential antigen disruption method rapidly classifies mAbs into epitope-related groups.
  • Clustering results showed significant concordance with traditional competition experiments.
  • The procedure demonstrated high throughput and scalability for antibody profiling.

Conclusions:

  • Differential antigen disruption provides an efficient approach to assess large populations of mAbs.
  • This method enables the selection of representative antibodies for exploring epitope complexity and function.
  • This technique advances antibody characterization and functional studies.